COCRYSTAL PHARMA, INC. Interest Expense, Other
COCRYSTAL PHARMA, INC. (COCP) reported Interest Expense, Other of $1.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-11.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseOther · last filed 2022-05-11
- COCRYSTAL PHARMA, INC. interest expense, other for the quarter ending 2022-03-31 was $1.00K, a 0.00% change year-over-year.
- COCRYSTAL PHARMA, INC. interest expense, other for the quarter ending 2021-09-30 was $1.00K, a 50.00% decline year-over-year.
- COCRYSTAL PHARMA, INC. interest expense, other for the quarter ending 2021-06-30 was $2.00K, a 0.00% change year-over-year.
- COCRYSTAL PHARMA, INC. interest expense, other for the quarter ending 2021-03-31 was $1.00K.
- COCRYSTAL PHARMA, INC. interest expense, other for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- COCRYSTAL PHARMA, INC. interest expense, other for fiscal 2011 was $42.77K.
| Period end | Interest Expense, Other 3 month | Interest Expense, Other 6 month | Interest Expense, Other 9 month | Interest Expense, Other 12 month |
|---|---|---|---|---|
| 2022-03-31 | $1.00K 10-Q · filed 2022-05-11 | |||
| 2021-09-30 | $1.00K 10-Q · filed 2021-11-15 | $3.00K derived: sum of 2 quarters · filed 2021-11-15 | $4.00K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $2.00K 10-Q · filed 2021-08-16 | $3.00K 10-Q · filed 2021-08-16 | ||
| 2021-03-31 | $1.00K 10-Q · filed 2022-05-11 | |||
| 2020-09-30 | $2.00K 10-Q · filed 2021-11-15 | $4.00K derived: sum of 2 quarters · filed 2021-11-15 | $6.00K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $2.00K 10-Q · filed 2021-08-16 | $4.00K 10-Q · filed 2021-08-16 | ||
| 2012-12-31 | $0.00 10-K · filed 2013-04-01 | |||
| 2012-03-31 | $3.33M 10-Q/A · filed 2012-10-02 | |||
| 2011-12-31 | $42.77K 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |